Tips for Recovery After Gynecologic Surgery

Surgery is an essential component in the management of patients with gynecologic cancers. Surgical procedures may be utilized to initially diagnose cancers of the uterus, cervix, ovary, vulva and vagina. In addition, many gynecologic cancers are primarily treated (and often cured) with surgery alone. Nearly all gynecologic surgeries fall into either one of two categories: … Read more

How is Endometriosis Different from Endometrial Cancer?

Endometriosis is a non-cancerous disorder that occurs when tissue lining the inside of the uterus, known as the endometrium, appears in other parts of the body. It usually is found in the lower abdomen or pelvis but can appear in virtually any organ or tissue. Endometrial cancer, by contrast, occurs when cells in the endometrium … Read more

PARP Inhibitor Drugs May Now be Standard Part of Follow-up Therapy for Some Ovarian Cancer Patients

On the strength of the results of a major international clinical trial, there is now a new standard of care for patients with an advanced form of ovarian cancer who have responded to initial chemotherapy. The trial, dubbed SOLO-1, found that these patients – newly diagnosed with ovarian cancer that carries a mutation in the … Read more

Breast Cancer Research: What’s the Latest?

Breast cancer research makes possible the development of new therapies for breast cancer. Through clinical trials and work in research labs, including those at Dana-Farber Cancer Institute, treatments and drugs are explored — and if successful, are later able to be offered to patients who need them. Breast cancer today is seen as not one, … Read more

Trials Open New Avenues of Endometrial Cancer Treatment

A new generation of drugs and drug combinations is changing the outlook for patients with endometrial cancer. The results of the first clinical trials of the new therapies were so promising that they’ve led researchers to launch follow-up trials to explore the potential for even better outcomes.  The trials are geared to patients diagnosed with … Read more

Is Spotting Between Periods a Sign of Cancer?

Vaginal bleeding—also known as spotting—between periods is common among women who have not yet reached menopause. Most commonly, it is caused by hormonal imbalances, stress, and vaginal dryness. Vaginal bleeding in post-menopausal women can, in some cases, be an early sign of cancer and should always be investigated further. Spotting is the primary symptom of … Read more

‘Organoids’ Could Aid Cancer Drug Selection

Tests on living “organoids” created from patients’ ovarian cancer cells proved more accurate than DNA sequencing in predicting tumors’ sensitivity or resistance to chemotherapy drugs – and combining the two methods worked even better, say scientists at Dana-Farber Cancer Institute. The investigators report in Cancer Discovery that ovarian cancer organoids – tiny, three-dimensional spheres of cells … Read more

Patient Lives Energetic Life After Cancer Treatment — With Help From an App

Before her vulvar cancer diagnosis, Ronda Cushman led an energetic life as a physical therapy assistant who exercised each morning. Chemotherapy treatment curtailed both passions, but now Cushman may have a new ally in regaining her strength – and caregivers a new way to monitor her health away from the hospital. This past spring, Cushman … Read more

Women’s Cancers: What You Should Be Screened For and When

It’s never too early or too late to work toward being your healthiest you. That’s the motto of National Women’s Health Week, an initiative developed to help women of all ages take control of their health. Following proper cancer screenings is an important part of maintaining health and well-being – and reducing your risk of … Read more

Breast Cancer Treatment: What’s the Latest?

Not only are more effective drugs for breast cancer coming to the clinic, but oncologists are making important progress in matching breast cancer treatment to specific patients and the molecular characteristics of their tumors. It’s also becoming more feasible to rachet the intensity of treatment up or down depending on the patient’s risk status, and … Read more

What Is Triple-Negative Breast Cancer?

Triple-negative breast cancer is a subtype of breast cancer where cancer cells do not contain estrogen receptors or progesterone receptors, and HER2 receptors are also absent or present at low levels. Triple-negative breast cancer accounts for roughly 15% of all breast cancer cases and can be somewhat more aggressive than hormone-positive or HER2-positive breast cancer.  Who is most at risk for … Read more